ArticleFrontiers in aging neuroscience2025
Leveraging object detection for early diagnosis of neurodegenerative diseases through radiomic analysis.
Article in Frontiers in aging neuroscience, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction: Early diagnosis of neurodegenerative diseases remains a formidable challenge in modern neuroimaging, due to subtle and heterogeneous brain deterioration patterns in early disease stages. Integrating artificial intelligence and radiomic analysis has emerged as a powerful paradigm for non-invasive biomarker discovery and precision diagnostics. In alignment with trends emphasizing cross-modality analysis, interpretability, and demographic generalization, this study introduces a novel approach leveraging object detection and disentangled representation learning to improve early detection sensitivity and reliability. Traditional radiomics frameworks often suffer from limited generalizability, rigid feature engineering, and confounding variability from age, imaging protocol, or anatomical variations, undermining clinical robustness. Methods: Our method addresses these limitations through a three-pronged strategy. We construct a hybrid representation framework separating age-related morphometric changes from disease-specific alterations. We introduce NeuroFact-Net, a dual-path variational encoder-decoder architecture supervised along anatomical and diagnostic axes, enhancing interpretability and facilitating trajectory analysis. Wedevise a Causal Disease-Aware Alignment (CDAA) strategy imposing population-level invariance and disease-specific consistency using contrastive learning, adversarial subgroup confusion, and maximum mean discrepancy constraints. Results and discussion: Experiments across multi-site MRl and PET datasets demonstrate superior diagnostic accuracy, domain transferability, and latent biomarker interpretability, validating its potential for clinical deployment in early-stage screening. This work contributes a scalable, interpretable, and causally grounded computational framework aligned with Al-enhanced neuroimaging advancements.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.